Galeterone
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Galeterone, covering 2023-03-15 to 2025-07-01. Get the full timeline:
Most recent: Clinical Trial Update: 1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma [Phase 2]